timolol has been researched along with uf 021 in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (35.00) | 18.2507 |
2000's | 12 (60.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuma, I; Kitazawa, Y; Masuda, K; Takase, M; Yamamura, H | 1 |
Azuma, I; Kitazawa, Y; Masuda, K; Yamamoto, T | 1 |
Abiko, T; Ishiko, S; Kato, Y; Kitaya, N; Mori, F; Nagaoka, T; Ogasawara, H; Yoshida, A | 1 |
Araie, M; Tamaki, Y; Tomidokoro, A; Tomita, K | 1 |
Hara, Y; Kodama, T; Miyamoto, F; Ohashi, Y; Okamoto, S; Shimamura, I; Toshino, A | 1 |
Kapik, BM; Stewart, JA; Stewart, WC | 1 |
Mertz, BP; Nordmann, JP; Rouland, JF | 1 |
Hanada, K; Ishioka, M; Shimazaki, J; Shimmura, S; Tsubota, K; Yagi, Y; Yamagami, J | 1 |
Jurkowska-Dudzińska, J; Kawa, P; Zagórski, Z; Zarnowski, T | 1 |
Kapik, B; Mertz, B; Nordmann, JP; Schwenninger, C; Shams, N; Yannoulis, NC | 1 |
Brown, A; Crockett, S; Kubilus, C; Shams, N; Stewart, JA; Stewart, WC | 1 |
Day, DG; Leech, J; Schacknow, PN; Sharpe, ED; Stewart, JA; Stewart, WC; Wand, M | 1 |
Hommer, A; Kapik, B; Shams, N | 1 |
Amano, S; Inoue, K; Inoue, Y; Kato, S; Okugawa, K; Oshika, T; Tomita, G | 1 |
Kimura, I; Mashima, Y; Oguchi, Y; Ohtake, Y; Tanino, T | 1 |
Day, DG; Henry, CJ; Jenkins, JN; Mundorf, TK; Sharpe, ED; Stewart, JA; Stewart, WC | 1 |
Kane, FE; Kapik, BM; McCarey, BE | 1 |
Călugăru, D; Călugăru, M | 1 |
Chen, XM; Li, N; Wei, ML; Yao, X; Zhou, Y | 1 |
Hong, SJ; Lai, YH; Wu, KY; Wu, PC | 1 |
2 review(s) available for timolol and uf 021
Article | Year |
---|---|
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Drug Combinations; Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2004 |
Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2006 |
14 trial(s) available for timolol and uf 021
Article | Year |
---|---|
Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Administration, Topical; Blood Pressure; Dinoprost; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Timolol | 1993 |
Clinical evaluation of UF-021 (Rescula; isopropyl unoprostone).
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Dinoprost; Drug Evaluation; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Timolol; Treatment Outcome | 1997 |
Effect of timolol and UF-021 (a prostaglandin-related compound) on pulsatile ocular blood flow in normal volunteers.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Blood Pressure; Dinoprost; Double-Blind Method; Eye; Heart Rate; Humans; Intraocular Pressure; Ophthalmic Solutions; Pulsatile Flow; Reference Values; Reproducibility of Results; Timolol | 1997 |
The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
Topics: Circadian Rhythm; Dinoprost; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Safety; Timolol; Visual Acuity | 1998 |
A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Chronic Disease; Depression, Chemical; Dinoprost; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Statistics, Nonparametric; Time Factors; Timolol | 1999 |
Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone.
Topics: Adrenergic beta-Antagonists; Aged; Dinoprost; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Optic Disk; Prospective Studies; Tears; Timolol; Visual Acuity | 2000 |
[Clinical evaluation of isopropyl unoprostone (Rescula), in the adjunctive treatment of primary open angle glaucoma].
Topics: Administration, Topical; Antihypertensive Agents; Dinoprost; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Prospective Studies; Sulfonamides; Thiophenes; Timolol | 2001 |
A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Dinoprost; Double-Blind Method; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pupil; Safety; Timolol; Visual Acuity; Visual Fields | 2002 |
Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Cross-Over Studies; Dinoprost; Double-Blind Method; Drug Evaluation; Exercise; Exercise Test; Female; Heart Rate; Humans; Male; Ophthalmic Solutions; Safety; Timolol | 2002 |
Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Cross-Over Studies; Dinoprost; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Safety; Sulfonamides; Thiophenes; Timolol; Treatment Outcome; Visual Acuity | 2003 |
Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Chemotherapy, Adjuvant; Dinoprost; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Timolol | 2003 |
[Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
Topics: Adult; Aged; Antihypertensive Agents; Betaxolol; Dinoprost; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Timolol; Visual Fields | 2004 |
Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Dinoprost; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Timolol; Treatment Outcome | 2005 |
Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Betaxolol; Dinoprost; Double-Blind Method; Eye Color; Eyelashes; Female; Glaucoma, Open-Angle; Hair Color; Humans; Hyperpigmentation; Incidence; Intraocular Pressure; Iris; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Photography; Timolol | 2004 |
4 other study(ies) available for timolol and uf 021
Article | Year |
---|---|
In vivo measurement of iridial circulation using laser speckle phenomenon.
Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Circulation; Blood Flow Velocity; Dinoprost; Intraocular Pressure; Iris; Lasers; Microspheres; Ophthalmic Solutions; Rabbits; Reproducibility of Results; Timolol | 1998 |
[The mechanism of corneal epithelial disorder induced by prostaglandin F2 alpha isopropyl unoprostone].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cell Division; Cells, Cultured; Corneal Diseases; Dinoprost; Epithelium, Corneal; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Timolol | 1998 |
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carteolol; Dinoprost; Drug Therapy, Combination; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Keratitis; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Risk Factors; Sulfonamides; Tears; Thiophenes; Timolol | 2003 |
Novel usage of intraocular pressure-lowering drugs as wound-healing inhibitors after trabeculectomy with cell culture and animal models.
Topics: Animals; Aqueous Humor; Benzalkonium Compounds; Biomarkers; Cell Culture Techniques; Cell Movement; Cell Proliferation; Collagen; Dinoprost; Fibroblasts; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Proliferating Cell Nuclear Antigen; Prostaglandins F, Synthetic; Rabbits; Timolol; Trabeculectomy; Wound Healing | 2013 |